Creative BioMart Biomarker offers carcinoembryonic antigen (CEA) testing outsourcing services for scientists in the field of biomarkers or disease researches. The service results ensure accuracy, specificity and repeatability.
Our testing services are only suitable for scientific research, not intended for clinical diagnosis and testing.
| CEA Testing |
| Analyte: |
CEA |
| Synonyms: |
carcinoembryonic antigen |
| Sample Type: |
plasma (heparin, EDTA), serum, cell culture supernatants or other biological fluids |
| Assay Platform: |
ELISA, ECL, IRMA |
| Biomarker Application Area: |
colorectal cancer, breast cancer, stomach cancer, liver cancer, lung cancer, etc. |
| * Perform three replicate tests on each sample, and include appropriate controls in each assay. |
Assay Background
CEA belongs to the immunoglobulin (Ig) superfamily, and it is also a glycoprotein involved in cell adhesion and plays a role in cell interaction and cell recognition. CEA has GPI-linked membrane anchoring properties, and its membrane-fixed region can be cleaved by phospholipase C and phospholipase D, and the cleaved product is released into the blood circulation system. CEA is related to various physiological functions in the body, such as cell adhesion, immune response and anoikis resistance. CEA is a broad-spectrum tumor biomarker with abnormal expression in a variety of malignant tumors, including colorectal cancer, breast cancer, gastric cancer, liver cancer, and lung cancer. At the same time, CEA expression levels can be used for cancer recurrence and tumor metastasis monitoring, as well as clinical staging. In addition, the increase in CEA concentration is also associated with inflammatory diseases. Although CEA is not recommended as a specific biomarker for a certain tumor, it still has clinical value. CEA can be used for therapeutic effect monitoring and prognostic evaluation, and can be used in combination with other biomarkers for cancer diagnosis.
Workflow of Biomarker Detection Services at Creative BioMart Biomarker
Customers provide: samples, reagents/kits (reagents/kits can also be provided or purchased by our company).
We provide: remaining samples and reagents, complete experimental reports (including experimental raw data, experimental procedures, instrument and reagent information, and professional result analysis).
Test cycle: 10 working days or less.
Why Choose Creative BioMart Biomarker for CEA Detection Service?
- High-quality technology platform
Creative BioMart Biomarker has established a number of technical platforms that can be used for biomarker detection. We provide ELISA, ECL and IRMA technology platforms for CEA testing, and you can choose according to your research needs.
- Experienced experts team
We have many experts with rich experience in biomarker testing. They always treat each test with a rigorous attitude and can always provide customers with accurate, precise and repeatable test results.
- Suitable for multiple sample types
Our biomarker testing service is applicable to several sample types, including serum, plasma, cell culture supernatant, etc. If your sample type is not common, you can contact us at any time to inquire about the testing service for your sample type.
- Fast testing and reasonable price
We have been committed to providing customers with efficient services to ensure that the experimental results are delivered within the predetermined time. Our testing services have reasonable and competitive prices in the industry, which can help customers reduce research costs.
If you are interested in our services, please feel free to contact us, Creative BioMart Biomarker is here to offer you professional and thoughtful service.
Reference:
- Lee, J. H.; Lee, S. W. The roles of carcinoembryonic antigen in liver metastasis and therapeutic approaches. Gastroenterology Research and Practice. 2017, 2017: 7521987.
